Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patidegib Topical Gel in Gorlin Syndrome
NCT03703310Phase 3Completed
- Sponsor
- Sol-Gel Technologies
- Start
- Feb 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of patidegib in Basal cell nevus syndrome (BCNS), sponsored by Sol-Gel Technologies. Started Feb 2019; status: completed.
02
Drugs
patidegib
03
Conditions
Basal cell nevus syndrome (BCNS)
Beyond the preview
Go deeper on NCT03703310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03703310.